Controlled drug delivery systems have been utilized to enhance the therapeutic effects of many drugs by delivering drugs in a time-dependent and sustained manner. Here, with the aid of 3D printing technology, drug delivery devices were fabricated and tested using a model drug (fluorophore: rhodamine B). Poly(ethylene glycol) dimethacrylate (PEGDMA) devices were fabricated using a two-photon polymerization (TPP) system and rhodamine B was homogenously entrapped inside the polymer matrix during photopolymerization. These devices were printed with varying porosity and morphology using varying printing parameters such as slicing and hatching distance. The effects of these variables on drug release kinetics were determined by evaluating device fluorescence over the course of one week. These PEGDMA-based structures were then investigated for toxicity and biocompatibility in vitro, where MTS assays were performed using a range of cell types including induced pluripotent stem cells (iPSCs). Overall, tuning the hatching distance, slicing distance, and pore size of the fabricated devices modulated the rhodamine B release profile, in each case presumably due to resulting changes in the motility of the small molecule and its access to structure edges. In general, increased spacing provided higher drug release while smaller spacing resulted in some occlusion, preventing media infiltration and thus resulting in reduced fluorophore release. The devices had no cytotoxic effects on human embryonic kidney cells (HEK293), bone marrow stromal stem cells (BMSCs) or iPSCs. Thus, we have demonstrated the utility of two-photon polymerization to create biocompatible, complex miniature devices with fine details and tunable release of a model drug.
Introduction
Recent advances in 3D printing, including the ability to construct complex structures with fine precision, open the door to rapid and facile production of controlled release devices (Acosta-Velez et al., 2018; Clark et al., 2017; Do et al., 2015; Fina et al., 2018; Goole and Amighi, 2016; Hollander et al., 2018; Khaled et al., 2018; Martinez et al., 2017; Zhang et al., 2017) . Newly developed technologies such as two-photon polymerization (TPP) enable researchers to prototype micro-and nanostructures with high resolution. Compared to typical fused deposition modeling printing (50-200 µm resolution) and stereolithography (∼20 µm resolution), TPP can be used to create structures with features of the order of approximately 100 nm resolution (Melchels et al., 2010) . With such high resolution and precision, TPP enables the fabrication of complex nanoscale devices (Timashev et al., 2016; Worthington et al., 2017) .
While historically this technique has been used primarily to create optical devices, micromachines and microfluidics, such high resolution and precision enables the fabrication of complex nanoscale devices that could directly influence cellular growth, differentiation and behavior. Several groups, including our own, have applied this ability to biological systems, namely to study cell motility and mechanical response, (Klein et al., 2010) and to encourage infiltration and alignment within TPP scaffolds (Timashev et al., 2016; Worthington et al., 2017) .
Owing to its tendency to hinder non-specific protein absorption, poly(ethylene glycol) (PEG) has been used extensively to increase drug stability and retention time of biopharmaceuticals (Ivens et al., 2015; Turecek et al., 2016) . Furthermore, methacrylated PEG (e.g., PEGDMA), which can undergo photocrosslinking, is one of the most widely studied platforms in tissue engineering, especially when co-crosslinked or otherwise functionalized with integrin binding peptides such as RGD (Bryant and Anseth, 2003; Clapper et al., 2008) . Many groups, including our own, have demonstrated that photocrosslinked PEGDMA and its close relatives are compatible with a wide variety of cell and tissue types (Adiguzel et al., 2017; Clapper et al., 2008; Xu et al., 2013; Zhou et al., 2016) . PEGDMA hydrogels, whose architecture can be tightly controlled using photopolymerization (Bryant and Anseth, 2003) , have also been used for a number of drug delivery applications, including stimuli-responsive systems (Aimetti et al., 2009; Lin and Anseth, 2009 ). Yet, the traditional photopolymerization methods used in these approaches are inherently limited in their ability to create micron-scale features with high precision. TPP, capable of overcoming this challenge, has been used to create simple PEGDMA scaffolds with some success (Ulasan et al., 2015) , but this powerful ability has not been fully characterized or realized in the context of pharmaceutics, controlled release, or tissue engineering.
In this study, we investigated the effect of manipulating a number of parameters during the TPP 3D printing process to determine if such changes could be used to control the release of a model drug, rhodamine B. Using TPP, PEGDMA devices were printed with varying parameters and their drug release kinetics were assessed according to five traditional drug delivery models. PEGDMA was chosen due to its biocompatible properties and its ability to be used as a photopolymer for TPP printing (Ulasan et al., 2015) . We also tested for any cytotoxic effects of the devices on a range of cell lines that are widely used for biomedical testing. We hypothesized that the 3D printing parameters of slicing, hatching, and pore size would affect drug release profiles of printed structures. The results obtained from this study provide a valuable foundation that connects TPP based 3D printing settings to controllable drug release. To the best of our knowledge, this is the first study to characterize the effects of TPP printing parameters on (model) drug release kinetics.
Materials and methods

Device design
Stereolithographic files of printable devices were designed and generated using AutoCAD software (Autodesk, San Francisco, California). The general design consisted of either a cuboid or a "woodpile" structure, which contained multiple layers of regularlyspaced cylinders, each layer lying in the x-y plane but rotated 90°c ompared to the previous layer. The overall dimensions of each device was 105 × 105 × 60 µm (LxWxH), unless otherwise noted. For woodpile structures, cylinder diameter and spacing were each varied according to the parameters listed in Table 1 . When 3D models are translated into a series of commands for line-by-line two-photon polymerization, the user must determine the line density. The 3D solid is first split into a series of horizontal layers in a process known as slicing. The distance between each of these layers is known as the slicing distance. Each of these layers is then split into a series of parallel lines in a process known as hatching. As with slicing, the distance between each line is known as the hatching distance. In our experiments, the slicing and hatching distances were each varied for cuboid and woodpile structures, with all other parameters held constant (Table 1) .
Device fabrication
Based on previous work and preliminary results, the optimal formulation to create repeatable TPP poly(ethylene glycol) structures containing sufficient fluorophore for detection was found to be: 88.3% wt PEGDMA (Mn of 575, viscosity of ∼57 cP, Sigma-Aldrich, St. Louis, MO), 2.7% wt Irgacure 369 (photoinitiator, BASF, Germany), and 10% wt rhodamine B (Sigma-Aldrich) mixture (10 mg/mL in water) or water only (no fluorophore) as the control. To facilitate adhesion of the printed structure to the substrate, we functionalized glass coverslips with polymerizable groups prior to their use as two-photon polymerization substrates (Worthington et al., 2017) . Briefly, we exposed glass substrates to oxygen plasma (Plasma Cleaner equipped with PlasmaFlo gas flow control, Harrick Plasma, Ithaca, NY) at an oxygen flow rate of 22.5 mL/min at 30 W radio frequency power for three minutes. The substrates were then submerged in a 1% solution of 3-(trimethoxysilyl)propyl methacrylate (Sigma-Aldrich) in hexanes (Fisher Scientific, Waltham, MA) overnight. We then rinsed the glass substrates in hexanes, dried them and stored them in an airtight container at room temperature until ready for use.
For each set of devices, the substrate was placed in the sample holder and a droplet of the formulation was placed in the center of the substrate which was a 30 mm diameter #1.5 thickness glass coverslip (CS-30R, Warner Instrument, Hamden, CT). The structures were created using a two-photon lithography system (780 nm laser, Nanoscribe GmbH) using a 25X objective (NA = 0.8). Laser power (100%), scanning speed (50,000 μm/s) and all other lithography parameters were held constant for all experiments. After fabrication, the structures were removed from the sample holder, submerged in deionized water for five minutes and dried at room temperature overnight in the dark.
Device morphology
The morphology of the printed devices was examined using scanning electron microscopy (SEM). Samples were mounted on an aluminum stub using double-sided carbon tape. These samples were then dried overnight in ambient air for 24 h prior to being coated with goldpalladium using an argon beam K550 sputter coater (Emitech Ltd., Kent, England). Once coated, samples were imaged using a Hitachi S-4800 SEM (Hitachi High-Technologies, Tokyo, Japan) at an accelerating voltage of 1 kV with the sample stage tilted at 30°.
Release of rhodamine B
Samples were initially imaged with an EVOS FL fluorescence microscope (Thermo Fisher, Waltham, MA) and used as the starting reference point for fluorophore release (starting concentration of 100%: Supplemental Fig. 1A ). Samples were imaged at the lowest brightness settings: 10% intensity at an exposure rate of 15 ms. Devices were then submerged in 3 mL of nanopure water and incubated in a shaking incubator set at 300 rpm and 37°C. Samples were collected at the following time points: 1, 3, 6, 12, 24, 48, 72, 96, 168 h. At each designated time point, the water was aspirated and the devices were left to dry for 5 min prior to imaging. Images of the devices were collected using a fluorescence microscope at the settings previously mentioned, then analyzed using ImageJ as described previously (see example in Supplemental Fig. 1B -C) (Gavet and Pines, 2010; McCloy et al., 2014) . In order to generate this standard curve, PEGDMA discs (4 mm × 50 µm) were fabricated using UV polymerization. Briefly, laminate molds were constructed using two standard glass slides with two layers of heavy duty aluminum foil (approximately 0.5 in. × 1 in.; total thickness ∼50 µm) on each end as spacers. These layers were clamped on each end using binder clips and each mold was filled with 60 mL of PEGDMA containing rhodamine B. The pre-polymerized formulations were the same as described above and to each other except for the amount of rhodamine B added, which ranged from 0 mg/mL to 2 mg/ mL. Each sample was photopolymerized by exposing the mold to high intensity UV light (Omnicure Series 2000 equipped with 8 mm liquid light guide, Excelitas Technologies, Waltham, MA) at a distance of 2 in. from the end of the light guide and an intensity of 6 W/cm 2 (measured at the source) for 50 s. After polymerization, each mold was carefully deconstructed, and the resulting films were rinsed by rapid submersion in excess deionized water three times to remove trace amounts of unreacted prepolymer. The films were then blotted with a laboratory napkin and a 4 mm biopsy punch was used to create uniform discs (n > 5) from the periphery of the film, where photobleaching had not occurred. After imaging as described above, our results confirmed that the amount of added rhodamine B was within the linear range of the standard curve and therefore the structures were not saturated with the fluorophore (Supplemental Fig. 2 ).
PEGDMA biocompatibilty
Human embryonic kidney 293 cells (HEK293, ATCC, Rockville, MD) and bone marrow stromal stem cells (BMSCs, ATCC) were maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco®, Life Technologies Corporations, Brooklyn NY) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 10 mM HEPES (Gibco®), 50 μg/mL gentamycin sulfate (Cellgro, Manassas, VA), 1 mM sodium pyruvate (Gibco®), and 1 mM Glutamax (Gibco®). Both cell types were incubated at 37°C and 5% CO 2 in a humidified atmosphere. Murine induced pluripotent stem cells (iPSCs) were generated as described previously (Tucker et al., 2013a; Tucker et al., 2013b; Worthington et al., 2016) . Pluripotency media comprised Dulbecco's modified Eagle's medium: Nutrient Mixture F-12 (DMEM/F12; Life Technologies, Gibco, Carlsbad, CA) with 15% fetal bovine serum (Life Technologies), 1% 100X nonessential amino acids (NEAA; Life Technologies), 0.4 mM L-glutamine (Life Technologies), 0.1 mg/mL Primocin (InvivoGen, San Diego, CA), and 8.88 ng/mL 2-mercaptoethanol (Sigma-Aldrich). Just before use, 2 U/mL of mouse recombinant leukemia inhibitory factor (mLif, ESGRO; EMD Millipore, Billerica, MA) was added and media were warmed to 37°C.
To test for cytotoxicity of the PEGDMA-based devices, 5 mL of complete media was added to 60 mm petri dishes that contained the PEGDMA devices and were incubated overnight at 37°C. The supernatant was then harvested and used as growth media to feed each cell line. The "conditioned" media was incubated with the cells for 24 h before cytotoxicity was analyzed. Cytotoxicity was assessed using an MTS assay (CellTiter 96®, Promega, Madison, WI) following manufacturer's instructions. In brief, cells were plated in a 96-well plate at a density of 1 × 10 4 cells/well in 100 µL of DMEM (+ supplements) for 24 h prior to treatments. The media was then aspirated and then the indicated supernatants (described above) were added at varying dilutions. The cultures were then incubated for 24 h, after which the media was removed, cells were washed with 1X PBS, and then replenished with fresh media. Then, 20 µL of MTS reagent was added and cells were incubated for a further 3 h. Finally, the absorbance was measured at 490 nm using a SpectraMax plus 384 Microplate spectrophotometer (Molecular Devices, Sunnyvale, CA). Relative cell viability was analyzed using untreated cells as the control group.
Statistical analysis
The loss of fluorescence was used as a means of quantifying drug release (Supplemental Fig. 1 ) and release curves were fit to five drug release models: zero order, first order, Higuchi, Hixson-Crowell, and Korsmeyer-Peppas. Model accuracy was determined using R-squared and Sy.x values, with
where n is the number of data points in the set (typically 24: 3 measurements at each of 8 time points) and K is the number of parameters fitted in the model. The most accurate model and extra sum-of-squares F-tests were used to test the null hypothesis that all release profiles within a given group could be modeled using the same parameters. Pvalue was two-sided and a value of less than 0.05 was considered to be statistically significant. Data were presented as mean ± the standard error of the mean, unless stated otherwise.
Results and discussion
In order to identify the potential connection between 3D printing settings and controlled drug release, we investigated the effects of varying printing parameters on controlled fluorophore release. Using a two-photon polymerization system, 3D printed devices were printed with varying slicing, hatching, spacing, and shape and were homogenously loaded with rhodamine B in order to assess controlled drug delivery functionality. Furthermore, the printed devices were analyzed for cytotoxic effects on a variety of cells in an effort to demonstrate the potentially wide applicability of this technology to multiple disease models.
Cylinder diameter
In this experiment, rhodamine B was homogenously encapsulated in the material (PEG) and thus can be assumed to be distributed equally across the entire volume. Meanwhile, diffusion is known to be dependent on the surface area available for transport. Hence, a higher surface area per volume should equate to more rapid transport. For an individual cylinder, this relationship becomes:
Where r is the cylinder diameter and h is cylinder length. Thus, for a constant cylinder length, decreasing the diameter increases the surface area to volume ratio. Accordingly, we hypothesized that the rate of rhodamine B released from PEG "woodpile" structures would increase as the diameter of cylinders decreased. The PEG structures created to test this first hypothesis matched the overall intended woodpile design (Fig. 1A-F) . It should be noted, however, that PEG structures are known to be hydrophilic and in this case, water accounts for roughly 10% of the mass. The majority, if not all, of this hydration can be presumed to have been lost upon dessication, which was required for SEM imaging. This drying effect likely contributed to slight deviations (e.g. shrinkage) in the appearance of the structures from their morphology prior to dessication (Fig. 1D-F) .
Release of rhodamine B from the woodpile structures most closely followed a Korsmeyer-Peppas model; R 2 values were higher and Sy.x values lower overall for this model than for the other four models (Supplemental Table 1 ). It is reasonable to anticipate that such pore obstruction in the 5 µm woodpile structure would inhibit release from the structure. Indeed, the initial rate of release of rhodamine B from the 5 µm woodpile structures was lower than that from the 10 or 15 µm structures (Fig. 1G) . Furthermore, the ultimate amount of rhodamine B released from the 5 µm structures (41%) was lower than the amount released from the 10 or 15 µm structures (51% and 53%, respectively; Fig. 1G ). These differences were further validated by comparing the mathematical parameters: the release rate constant (k) for the 5 µm structures was roughly half the value of its larger diameter counterparts, while the release rate exponent (n) was nearly 1.5 times greater. Indeed, the possibility that these three structures share a common release model is statistically unlikely (p < 0.0001). However, these data do not support the hypothesis that decreasing cylinder diameter increases release rate from woodpile structures. On the contrary, structures composed of the smallest cylinders released the model drug more slowly than structures with larger cylinders. This difference in release can likely be attributed to the occlusion of water due to the small pore size of the structures containing 5 µm cylinders. Potentially indicating that there are pore size limitations for water infiltration. Furthermore, differences in pore size (spaces between cylinders) in this experiment could have confounded the effect of cylinder size. With a larger pore size, more water would be more readily able to enter the device and thus increase the rate of fluorophore diffusion and release. Since cylinder diameter and spacing were directly linked in this experiment, the expected effect of increasing the cylinder diameter (decreasing the release rate) because of the decrease in surface area to volume ratio could have been offset by the concomitant expected effect of increasing the spacing between cylinders (increasing release rate).
Cylinder spacing
In order to gain more clarity into the effects of woodpile morphology on rhodamine B release rate, the effects of cylinder diameter and cylinder spacing were separated. In theory, increasing the space between cylinders in a woodpile structure will increase the concentration gradient, boosting the driving force for diffusion of rhodamine B out of the cylinder. In essence, smaller pores may occlude water infiltration while larger pores allow for higher rates of diffusion. Thus, we hypothesized that for PEG woodpile structures with constant cylinder diameters, increasing the spacing between cylinders would increase the release rate of encapsulated rhodamine B.
As in the initial experiment described above, the PEG woodpile structures resembled their respective 3D models reasonably well ( Fig. 2A-D) . While a structure with 15 µm spaces between cylinders was initially included in this experiment, these structures could not be reliably fabricated and were often absent from the sample surface, most likely because the large spacing prevented adequate intra-structural adherence of the cylinders to one another. Thus, this group was excluded from further analysis. Regardless, the initial rate of release of rhodamine B from the structures with larger spacing between cylinders (9.29 µm) was higher than that from the structures with smaller spacing (5 µm; Fig. 1E ). Meanwhile, the amount of rhodamine B that had been released at the end of the experiment was relatively similar between the structures with larger spacing (44%) compared to smaller spacing (42%; Fig. 1E ). Furthermore, both release profiles closely followed a Korsmeyer-Peppas model (Supplemental Table 2 ), and their regression parameters were significantly different from one another (p < 0.0001). In fact, the release constant for structures with larger spacing was approximately three times larger and their release exponent half the value of the smaller-spaced structure (Supplemental Table 2 ). These data support the hypothesis that increasing spacing between cylinders in a PEG woodpile device increases the release rate of encapsulated rhodamine B. Also, as was observed here, the planned porosity should be considered carefully, as pores that are too large can cause structural integrity issues of the printed device (Sabree et al., 2015) . 
Slicing and hatching distance
For any given material chemistry, the structural outcomes of TPP devices are highly dependent on selected TPP parameters, such as slicing and hatching distance. Given the impact of these subtle adjustments on final morphology, it was speculated that slicing and hatching distance may also play a role in the diffusion kinetics of encapsulated molecules from TPP devices. Slicing and hatching distance are each inversely correlated to line density within a structure. Thus, increasing either parameter should result in structures of decreasing density. In theory, this change would in turn enhance the mobility of encapsulated molecules and speed their diffusion out of the structure. Thus, we hypothesized that increasing slicing or hatching distance of PEG structures would increase the rate and ultimate amount of rhodamine B released from the device. This expectation is congruent not only with our second hypothesis (supported by Fig. 2 ), but also with findings that suggest increased release rate of small molecules from highly porous mesoporous matrices (Horcajada et al., 2004) , lidocaine from highly porous poly (lactic-co-glycolic) microparticles (Klose et al., 2006) , and vancomycin from calcium phosphate cement matrices (Schnieders et al., 2011) . In order to separate the effects of slicing and hatching from those of cylinder size and spacing, as previously described, we first tested the slicing and hatching hypothesis using a simple cuboid structure. In all cases, the PEG cuboids were qualitatively similar to the originally designed model (Fig. 3A-B) and to one another. Increasing slicing increased the initial rate of rhodamine B release from the cuboids (Fig. 3C) . Furthermore, the total amounts of rhodamine B released at the end of the experiment were 42, 44 and 50% for slicing distances of 0.05, 0.1 and 0.15 µm, respectively. Once again, all the release profiles followed the Korsmeyer-Peppas model (Supplemental Table 3 ), and significant differences were observed between their regression parameters (p < 0.0001). The modeled release rate constant increased with increasing slicing distance while the release rate exponent decreased or stayed the same (Supplemental Table 3 ). Increasing the hatching distance had a similar effect on rhodamine B release from PEG cuboids (Fig. 3D) . Release profiles followed a Korsmeyer-Peppas model and non-linear regression parameters were significantly different from one another (p < 0.0001) and responded to hatching distance in the same manner as slicing distance (Supplemental Table 3 ). These data support the hypothesis that increasing slicing or hatching distance would boost release from TPP PEG structures. Additionally, the release of rhodamine B from these cuboids was markedly slower than release from analogous woodpile structures. This difference can likely be attributed to the lower surface area and limited porosity of the cuboids compared to the woodpiles, which likely led to less water infiltration and thus decreased the rate of rhodamine B diffusion from the devices.
The effects of varying slicing and hatching distances were then investigated with woodpile structures described previously. While in all cases the resulting PEG woodpiles (Fig. 4A-F) resembled the model (which is shown in Fig. 1B) , small slicing or hatching distances resulted in deterioration of the structure at the edges of the device (Fig. 4A, D) . Despite this structural difference, the profiles of rhodamine B release from these PEG devices still followed a Korsmeyer-Peppas model (Supplemental Table 4 ) and were remarkably similar to one another. The total amount of rhodamine B released from structures with slicing or hatching distances of 0.05 µm (49 or 52%, respectively) was slightly lower than that from 0.1 and 0.15 µm slicing or hatching (56 and 59, or 58 and 58%, respectively; Fig. 4G-H) . These subtle differences were reflected as significant differences (p < 0.05 and p < 0.0001, for varied slicing and hatching, respectively) between the regression parameters for these release profiles. However, absolute differences between the regression parameters were small compared to the effects of other parameters investigated (Supplemental Table 4 ), suggesting that at this scale, the kinetics of rhodamine B release from PEG woodpile structures are dictated mostly by structure geometry, with slicing and hatching distance playing a lesser but tangible role.
At the end-points of the release studies (one week) presented in Figs. 1-4 , the devices did not completely release their payloads (maximum cumulative release was ∼55%), while release appeared to have slowed substantially. There are a number of possible explanations as to why this may have occurred. First, small amounts of rhodamine B may still have continued to be released past the final time point, but the incremental change in fluorescence was not great enough to be detected. Second, since rhodamine B is photoactive, a proportion of it may have acted as a second photoinitiator during two-photon polymerization, thus becoming part of the crosslinked polymer via covalent bonding (Wagner, 1971) . However, given the relatively high concentration of rhodamine B included in the formulation and the presence of the primary photoinitiator, which is more sensitive and efficient, we presume that rhodamine B activation during fabrication occurred to only a minor degree. Furthermore, even though this event may prevent the full release of the rhodamine B from the devices, it is a variable that is expected to be consistent between all groups. Finally, the saturation effect could also be due in part to the photodegradation properties of rhodamine B. Since the photodegradation of rhodamine B is relatively low (about 10% loss over 168 h) (Do et al., 2017) , we believe that this contribution was also minimal. Several well-known groups suggest that only the first 60% of release should be used for mathematical modeling of drug delivery systems (Bruschi, 2015; Ritger and Peppas, 1987) , so conclusions about general release behavior can confidently be drawn from the type of data we present here.
All of our release profiles followed a Korsmeyer-Peppas model, which enables the release rate exponent, n, to be used to identify the release mechanisms at play. Typically, values around 0.5 indicate Fickian diffusion and those higher than 0.5 signify some degree of polymer relaxation effects, including swelling and crazing (Bruschi, 2015) . The values we report for TPP PEGDMA structures are between 0.14 and 0.35, suggesting that release kinetics are likely dictated by diffusion rather than relaxation within the polymer network. However, even the highest rate exponent we found, 0.35, is quite low compared to the 0.5 "gold standard" of Fickian behavior. This discrepancy could be due to a number of factors, including sample geometry and covalent drug binding. First, distinct values of n that correspond to Fickian kinetics are known to depend on sample geometry, with cylindral and spherical samples having Fickian n-values of 0.45 and 0.43, respectively (Ritger and Peppas, 1987) . Since the structures we created comprise a series of overlapping polymer lines on the sub-micron scale and overlapping cylindrical structures on the microscale, the geometry at hand is quite complex compared to the geometric systems used to form historical assumptions about n-values and Fickian behavior. Thus, it is plausible that n-values in the range of 0.15 to 0.35 are characteristic of release behavior that follows Fick's law for these intricate structures. Future studies should focus on controlling various parameters in order to test this hypothesis and to determine characteristic nvalues for various release mechanisms. Secondly, a limited amount of covalent incorporation of the model drug is likely to have occurred during two-photon polymerization as a result of unavoidable Type II photoinitiation and associated hydrogen abstraction described above. Because release kinetics were inferred based on fluorescence of the structures, which included these presumptively bound molecules, the apparent release kinetics could have been dampened by the phenomenon. Although Type II photoinitiation has not been studied extensively in the context of two-photon polymerization, it usually plays only a minor role in traditional photopolymerization reactions and thus, we do not expect its effects to be dominant here (Lee et al., 2004) .
PEGDMA biocompatibility
In order to be clinically translatable, the devices described here must not only be effective in delivering the intended therapeutic, but also show evidence of being biocompatible. With photopolymerization in particular, the presence of free radicals is at least one concern in terms of cytotoxicity (Platel et al., 2008) . While exposure to photoinitiators and high intensity light during photopolymerization certainly causes cellular death to varying degrees depending on the initiator used (Williams et al., 2005) , fabrication of the two-photon drug delivery systems we describe here occurs independently of cells and tissue, protecting them from this particular risk. Still, some photoinitiator fragments likely remain immediately after fabrication, so we sought to validate the compatibility of these in the context of our model system. We did so for prototype TPP devices using a range of cell types, including cells that may be used for tissue engineering purposes, such as iPSCs and BMSCs. In our experience, stem cell lines like these are especially sensitive to small changes in their culture conditions, qualifying their use at the 24-hour time point for determining overall biocompatibility. This acute response is likely due to stem cells' characteristically high rate of self-renewal, which can reasonably be assumed to accelerate the effects of any cytotoxic media components. Media conditioned with presumptive leached products from the PEGDMA material had no significant cytotoxic effect when incubated with these various cell types (Fig. 5) . These results build upon what others have also noted; crosslinked PEGDMA has been shown to have no cytotoxic effects on other cell lines such as NIH-3T3 fibroblasts (Adiguzel et al., 2017; Clapper et al., 2008; Ulasan et al., 2015; Xu et al., 2013; Zhou et al., 2016) . The lack of cytotoxic effects of the printed PEGDMA material towards stem cells is particularly important Fig. 4 . Effect of slicing and hatching distance on rhodamine B release from TPP woodpile structures. A-F: Representative scanning electron micrographs of PEG woodpile structures with 10 µm cylinders created using a slicing distance of 0.05, 0.1 or 0.15 µm at constant hatching distance or a hatching distance of 0.05, 0.1 or 0.15 µm at a constant slicing distance, respectively. Scale bars represent 25 µm. G-H: Release profiles (data points) and best-fit Korsmeyer-Peppas regression curves (lines) of rhodamine B diffusion from the devices shown in A-F with varying slicing (G) or hatching (H) distances. Error bars represent standard error of the mean; n = 3. when considering these PEGDMA-based devices for tissue engineering purposes, as it demonstrates their versatility for a wide range of applications and tissue types. Further validation with more precise cell and tissue types of interest, as well as in an animal model, will certainly be required before two-photon polymerized drug delivery systems can be employed for any specific application.
Conclusions
In this study, we demonstrated that the manipulation of TPP based 3D printing parameters can be used to control drug release from printed constructs. Specifically, device design, porosity, and material density all play a role in the kinetics of small molecule release from two-photon polymerized structures. Since these can be tuned independently of material chemistry, this method of control has potential cost and time saving benefits over traditional controlled release methods. Additional future studies aimed at utilizing other drug candidates such as proteins and lipophilic drugs would further demonstrate the versatility of this approach. Fig. 5 . Biocompatibility of photopolymerized poly(ethylene glycol). The viability of human embryonic kidney cells (HEK 293), bone marrow stromal stem cells (BMSC) or mouse induced pluripotent stem cells (iPSC) was analyzed through an MTS assay after 24 h of incubation in "conditioned" media. The cells were incubated with "conditioned" media that was made by incubating photopolymerized poly(ethylene glycol) dimethacrylate samples in cell culture media for 24 h . Error bars represent standard deviation; n = 4.
